NCT07756918

Brief Summary

The study is randomized and single-blinded. Ethical approval is taken from ethical committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in group A \& B through sealed envelope method by Non-probability Convenient random sampling technique. Subjects in Group A will receive Shock wave therapy. Group B will receive Dry needing.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
1mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Oct 2025Aug 2026

Study Start

First participant enrolled

October 15, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 11, 2026

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2026

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Last Updated

August 11, 2026

Status Verified

August 1, 2026

Enrollment Period

10 months

First QC Date

July 21, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

dry needlingextra-corporeal shock wave therapypainjumper knee

Outcome Measures

Primary Outcomes (3)

  • numeric pain rating scale

    pain will be evaluated through numeric pain rating scale, The Numeric Pain Rating Scale (NPRS) is an 11-point scale from 0 to 10. Patients select a whole number matching their pain intensity, where 0 means no pain and 10 means the worst pain imaginable. Scores are grouped into mild (1-3), moderate (4-6), and severe (7-10) pain levels

    Pre and 6 week post interventional

  • Victorian Institute of Sport Assessment - Patella

    Knee Function measured through the VISA-P (Victorian Institute of Sport Assessment - Patella) score has a maximum value of 100 points for a healthy, pain-free individual, with a theoretical minimum of 0. It consists of eight questions assessing pain, functional severity, and sports capacity. You can calculate your score interactively using online tools like the VISA-P Questionnaire.

    Pre and 6 week post interventional

  • Quality Of life measure through KOS-ADLS

    The Knee Outcome Survey Activities of Daily Living Scale (KOS-ADLS): The KOS-ADLS is a 14-item self-reported questionnaire designed to evaluate symptoms and limitation during activities of daily living among patients with various knee disorders

    Pre and 6 week post interventional

Study Arms (2)

Extracorporeal Shockwave therapy

EXPERIMENTAL

Extracorporeal Shockwave therapy

Other: Extracorporeal Shockwave therapy

Dry needling

EXPERIMENTAL

Dry needling

Other: Dry Needling

Interventions

The participants in this group will receive Extracorporeal shockwave therapy with baseline treatment. The Frequency of sessions will be 3-5 sessions. The Intensity of the exercise related to energy levels as Low to medium energy flux density (EFD) ranges from 0.08 to 0.28 mJ/mm²

Extracorporeal Shockwave therapy

Frequency Will be 3 sessions per week. Repeated sessions over several weeks are often necessary for optimal tendon remodeling and pain relief. Intensity will be according to the depth and response-based application, Needles are inserted into myofascial trigger points (MTrPs) or directly into tendon tissue (peritendinous or intra-tendinous)

Dry needling

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants of either gender between the age of 18-35 years with a confirmed diagnosis of jumper's knee for more than 1 month.
  • Confirmed diagnosis of jumper's knee for more than 1 month.
  • Pain NPRS (Numeric Pain Rating Scale) score greater than 4 at the first evaluation.

You may not qualify if:

  • Surgery around the knee joint within the last 6 months.
  • Chronic knee joint disease.
  • Knee pain management with corticosteroid injections in the last 3 months.
  • Trauma history
  • Systemic illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hameed Latif Hospital

Lahore, Punjab Province, 54000, Pakistan

RECRUITING

Related Publications (2)

  • Vulpiani MC, Vetrano M, Savoia V, Di Pangrazio E, Trischitta D, Ferretti A. Jumper's knee treatment with extracorporeal shock wave therapy: a long-term follow-up observational study. J Sports Med Phys Fitness. 2007 Sep;47(3):323-8.

    PMID: 17641600BACKGROUND
  • Tiemessen IJ, Kuijer PP, Hulshof CT, Frings-Dresen MH. Risk factors for developing jumper's knee in sport and occupation: a review. BMC Res Notes. 2009 Jul 8;2:127. doi: 10.1186/1756-0500-2-127.

    PMID: 19586529BACKGROUND

MeSH Terms

Conditions

Pain

Interventions

Extracorporeal Shockwave TherapyDry Needling

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitationComplementary Therapies

Study Officials

  • Waqas Qadir, DPT

    Study Principal Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amna Shahid, t-dpt

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Clinical Trail
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2026

First Posted

August 11, 2026

Study Start

October 15, 2025

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

August 11, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations